Study Evaluating Multifaceted Support for the Implementation of Recommendations for the Prevention and Management of Anemia in Intensive Care Units
Condition(s) studied
Investigational drug(s) / intervention(s)
implementation of recommendations: The study will be organized into three periods: * a pre-implementation phase, with no changes to usual care; * a period of implementation of the recommendations; * a post-implementation phase.
Study summary
STOP-A is a prospective, multicenter data study aimed at demonstrating the impact of multifaceted support for the implementation of recommendations on the prevention and management of anemia in intensive care, compared to previous practices, on hospital mortality in adult patients hospitalized in intensive care for ≥2 days. The timing of implementation in each center is determined randomly by stepped-wedge randomization.
As such, this is a pragmatic study that meets the international PRECIS-2 criteria.
Eligibility
Primary outcome measure(s)
- evaluate the impact of multifaceted support for STOP-A implementation on hospital mortality, taking into account the stepped wedge design structure. — Day 0 to Day 90
in-hospital mortality, up to day 90
Trial sites (27)
| Facility | City | Region | Status |
|---|---|---|---|
| réanimation médicale CHU ANGERS | Angers | France | |
| Ch Victor Dupouy | Argenteuil | France | |
| CHRU BREST SITE HOPITAL CAVALE BLANCHE, réanimation chirurgicale | Brest | France | |
| CHRU BREST SITE HOPITAL CAVALE BLANCHE, réanimation médicale | Brest | France | |
| Ch Chartres Louis Pasteur-Le Coudray | Chartres | France | |
| Ch de Cholet | Cholet | France | |
| HOPITAL GABRIEL MONTPIED - CHU63, Réanimation Médico-Chrirugicale | Clermont-Ferrand | France | |
| HOPITAL GABRIEL MONTPIED - CHU63, Réanimation Neurochirurgicale | Clermont-Ferrand | France | |
| CHU Grenoble-HOPITAL SUD - CHU38 | Grenoble | France | |
| CH de LAVAL | Laval | France | |
| Centre Hospitalier Du Mans | Le Mans | France | |
| Hopital St Eloi Chu Montpellier | Montpellier | France | |
| Chru Nancy - Hopitaux de Brabois | Nancy | France | |
| Hopital Laenec, CHU Nantes | Nantes | France | |
| Hôtel Dieu, CHU Nantes | Nantes | France | |
| Gcs Irm Beaujon Moleculaire Act, Ap-Hp | Paris | France | |
| Hopital Cochin Tarnier Aphp | Paris | France | |
| Hu Est Parisien Site St Antoine Aphp | Paris | France | |
| Hu Paris Nord Site Bichat Aphp | Paris | France | |
| HU PITIE SALPETRIERE APHP, Réanimation Chirurgicale | Paris | France | |
| HU PITIE SALPETRIERE APHP, Réanimation Neuro-Chirurgicale | Paris | France | |
| CHU LA MILETRIE, réanimation neurochirurgicale | Poitiers | France | |
| Chru Rennes Site Pontchaillou | Rennes | France | |
| Hopital de Hautepierre | Strasbourg | France | |
| Hopital Haut-Leveque - Chu | Talence | France | |
| Hopital Purpan Chu Toulouse | Toulouse | France | |
| Chru Trousseau - Chambray | Tours | France |
More University Hospital, Angers trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07771192 on ClinicalTrials.gov ↗ ← All trials in France